Hematology

Martine Chamuleau
- Hematology - Medical Specialist
- CCA - Cancer biology and immunology - Medical Specialist
- CCA - Treatment and quality of life - Medical Specialist
Person: Academic
19912021
Nick de Jonge
- Hematology - Medical Specialist
Person: Academic
20182018
Dave de Leeuw
- Hematology - Medical Specialist
Person: Academic
20112020

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: The HOVON-SAKK-132 trial
Löwenberg, B., Pabst, T., Maertens, J., Gradowska, P., Biemond, B. J., Spertini, O., Vellenga, E., Griskevicius, L., Tick, L. W., Jongen-Lavrencic, M., Kooy, M. V. M., Vekemans, M-C., van der Velden, W. J. F. M., Beverloo, B., Michaux, L., Graux, C., Deeren, D., Weerdt, O. D., Esser, J. W. J. V., Klein, M. B. S. K. & 26 others, Gadisseur, A., Westerweel, P. E., Veelken, H., Gregor, M., Silzle, T., Lammeren-Venema, D. Ë. V., Moors, I., Breems, D. A., Hoogendoorn, M., Legdeur, M-C. J. C., Fischer, T., Kuball, J., Porkka, J. C. K., Juliusson, G., Meyer, P., Höglund, M., Gjertsen, B. T., Janssen, J. J. W. M., Huls, G., Passweg, J., Cloos, J., Valk, P. J. M., Elssen, C. H. M. J. V., Manz, M. G., Floisand, Y. & Ossenkoppele, G. J., 23 Feb 2021, In: Blood. 5, 4, p. 1110-1121 12 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Wulf, G. G., Altmann, B., Ziepert, M., D’Amore, F., Held, G., Greil, R., Tournilhac, O., Relander, T., Viardot, A., Wilhelm, M., Wilhelm, C., Pezzutto, A., Zijlstra, J. M., Neste, E. V. D., Lugtenburg, P. J., Doorduijn, J. K., Gelder, M. V., van Imhoff, G. W., Zettl, F., Braulke, F. & 9 others, Nickelsen, M., Glass, B., Rosenwald, A., Gaulard, P., Loeffler, M., Pfreundschuh, M., Schmitz, N., Trümper, L. & for the ACT-2 study investigators, Jan 2021, In: Leukemia. 35, 1, p. 143-155 13 p.
Research output: Contribution to journal › Article › Academic › peer-review
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: The UPSIDE study protocol
Spierings, J., van Rhenen, A., Welsing, P. M. W., Marijnissen, A. C. A., de Langhe, E., del Papa, N., Dierickx, D., Gheorghe, K. R., Henes, J., Hesselstrand, R., Kerre, T., Ljungman, P., van de Loosdrecht, A. A., Marijt, E. W. A. F., Mayer, M., Schmalzing, M., Schroers, R., Smith, V., Voll, R. E., Vonk, M. C. & 5 others, Voskuyl, A. E., de Vries-Bouwstra, J. K., Walker, U. A., Wuttge, D. M. & van Laar, J. M., 18 Mar 2021, In: BMJ Open. 11, 3, e044483.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

1 Membership of board

HOVON Data Centre, Rotterdam, Netherlands (External organisation)
Martine Chamuleau (Member)
1 May 2010 → 1 Sep 2019
Activity: Membership › Membership of board

Hematology

Network

Dive into details

Martine Chamuleau

Nick de Jonge

Dave de Leeuw

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: The HOVON-SAKK-132 trial

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: The UPSIDE study protocol

HOVON Data Centre, Rotterdam, Netherlands (External organisation)